Joel Greenblatt fit · Magic Formula - high ROIC + cheap EV/EBIT
Is Regeneron Pharmaceuticals, Inc. (REGN) a Joel Greenblatt Stock?
Low Magic Formula score - expensive, low ROIC, or both.
45/100
DMixed signals
2/5 criteria passed
+10 sector-quality lift. Top-quintile within its sector on 5 of 5 quality metrics. Raw pillar score 35 → lifted to 45 before grade derivation.
Joel Greenblatt's Criteria, Applied to REGN
EBIT/EV yield ≥ 10%
key5.0%
ROIC ≥ 25%
key8.5%
EV/EBIT ≤ 12
20.0x
Gross margin ≥ 30%
84.5%
Earnings yield ≥ 6%
6.1%
How REGN Scores on Other Strategies
Live Financial Snapshot
Market cap
$62.97B
P/E (TTM)
16.4x
ROIC (TTM)
8.53%
Gross margin
84.55%
Other Joel Greenblatt fit reports
Frequently Asked Questions
What is REGN's Joel Greenblatt fit score?
REGN scores 45/100 on our Joel Greenblatt fit engine - grade D. Low Magic Formula score - expensive, low ROIC, or both.
Does Joel Greenblatt actually own REGN?
Our score is computed from financial fundamentals against Joel Greenblatt's published criteria. We don't claim that Joel Greenblatt personally owns or recommends REGN.
How often is this score updated?
REGN's Joel Greenblatt fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Key terms in this analysis
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Joel Greenblatt personally owns or recommends REGN.